AzTrials
AzTrials

Biliary CannulationNCT03707613

Learning Curve of Double-wire Cannulation Technique During Endoscopic Retrograde Cholangiopancreatography (ERCP)

A study testing DWT learning curve in people with Biliary Cannulation and Endoscopic Retrograde Cholangiopancreatography, run by Air Force Military Medical University, China at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Selective cannulation is considered the most challenging step for most of endoscopic retrograde cholangiopancreatography (ERCP). Wire-guided cannulation is the standard technique for initial cannulation. When meeting difficulty, double wire technique (DWT) is widely used. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
DWT learning curve
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteChina
Study dates
15 Oct 2018to 29 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged 18-90 with native papilla
  • patients with diffcult cannulation of bile duct
  • Inadvertent pancreatic duct cannulation

Who cannot join

  • Contraindications of ERCP
  • Major or minor pancreatic duct as the targeted duct
  • Prior EST or needle-knife precut before DWT
  • Surgically altered gastrointestinal anatomy
  • Papillary carcinoma or stone impaction within papilla
  • Complete pancreas divisum
  • Pregnant or breastfeeding women
  • Unwilling or inability to provide consent

Trial locations and contacts

1 site in 1 country.

China1 site
  • Endoscopic center, Xijing Hospital of Digestive Diseases

    Xi'an, Shaanxi, 710032

Other trials in China

About this study

Official title: Learning Curve of Double-wire Cannulation Technique During Endoscopic Retrograde Cholangiopancreatography(ERCP): a Pilot Study

Selective cannulation is considered the most challenging step for most of endoscopic retrograde cholangiopancreatography (ERCP). Wire-guided cannulation is the standard technique for initial cannulation. When meeting difficulty, double wire technique (DWT) is widely used. With one guidewire occupying pancreatic duct(PD) , the following cannulation of CBD with a sphincterome preloaded with another guidewire often becomes feasible.

When performing DWT, a sphincterotome should enter the common duct of papilla through a small orifice and be placed in the left and upper direction of PD guidewire. Then another guidewire can be advanced into bile duct. As an advanced cannulation technique, DWT can be successfully performed in up to 80% of difficult patients. However, it can be technically difficult, especially for trainees or endoscopists without adequate experience.

Here we planned to prospectively record the procedures of double-wire cannulation by two trainees without prior experience of DWT. This study aims to delinate the learning curve of DWT and its safety by trainees.

Being tested
DWT learning curve
Keywords
ERCP, double guidewire technique, learning curve

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DWT learning curveProcedure or surgery

    trainees learn to perform DWT after unsuccessful initial cannulation

Study groups in NCT03707613
Study groupRoleWhat they receive
DWT learning curveExperimentalInitial cannulation is performed with a wire-guided sphincterotome by a trainee. If the cannulation proves difficult (cannulation time >10min, cannulation attemtps >5 or inadvertent PD cannulation >1) and PD is inadvertently entered, DWT will be performed by one of the two trainees. If DWT fails within 5min or 5 attempts, a trainer will take over and continue the cannulation. To prevent PEP, all patients receive prophylactic PD stent and post-ERCP rectal indomethacin. Aggressive hydartion will be administrated at the discretion of endoscopists.
Receives: Procedure: DWT learning curve

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Successful cannulation of bile duct within 5min or 5 attempts of cannulation

    It was defined by assurance of entering bile duct through cholangiogram during fluoroscopy.

    Measured: 3 hours

Secondary outcomes (5)
  1. Successful cannulation time with DWT by trainees

    Successful cannulation time was defined by the time taken from the begining of DWT to entering bile duct successfully

    Measured: 3 hours

  2. Cannulation attempts with DWT by trainees

    One cannulation attempt was defined by touching papilla for more than 5 seconds.

    Measured: 3 hours

  3. Precut rate

    Precut includes the procedure of cannulation involving needle knife or dual knife and transpancreatic precut by a sphincterotome.

    Measured: 3 hours

  4. post-ERCP pancreatitis(PEP)

    PEP is defined according to Cotton's criteria. The severity classification is based on revised Atlanta criteria.

    Measured: 48 hours

  5. Overall ERCP-related complications

    Overall ERCP-related complations include PEP, bleeding, perforation, cholangitis and others, which is defined by Cotton's criteria.

    Measured: 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2018
  2. Study start15 Oct 2018
  3. Primary completion28 Aug 2019
  4. Study completion29 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03707613
Sponsor's protocol ID
KY20180081-3
Status last verified
Jan 2020
First submitted
12 Oct 2018
Last updated
27 Jan 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wang X, Ren G, Xi Y, Luo H, Liang S, Wang B, Tao Q, Luo B, Qin Q, Farrell JJ, Guo X, Wu K, Pan Y. Learning curve of double-guidewire technique by trainees during hands-on endoscopic retrograde cholangiopancreatography training. J Gastroenterol Hepatol. 2020 Dec;35(12):2176-2183. doi: 10.1111/jgh.15120. Epub 2020 Jun 23.

    PubMed 32473040

Questions about this trial

What is this clinical trial studying?

A study testing DWT learning curve in people with Biliary Cannulation and Endoscopic Retrograde Cholangiopancreatography, run by Air Force Military Medical University, China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Successful cannulation of bile duct within 5min or 5 attempts of cannulation (time frame: 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03707613, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in